<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.976165</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The polymorphisms of MIR31HG gene is correlated with alcohol-induced osteonecrosis of the femoral head in Chinese Han male population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>JianFei</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zeng</surname>
<given-names>Fan</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xiong</surname>
<given-names>Jun</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1879717"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Orthopedic Trauma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University</institution>, <addr-line>Haikou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Chong Yin, Affiliated Hospital of North Sichuan Medical College, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Jacek Gagala, Medical University of Lublin, Poland; Varun Sharma, NMC Healthcare (NMC Genetics), India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jun Xiong, <email xlink:href="mailto:jiejunbing@126.com">jiejunbing@126.com</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Bone Research, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>11</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>976165</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>07</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>10</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Liu, Wang, Chen, Zeng and Xiong</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Liu, Wang, Chen, Zeng and Xiong</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Alcoholic osteonecrosis of the femoral head (ONFH) is a multifaceted illness that seriously disturbs the patients&#x2019; quality of life. The role of lncRNAs in alcoholic ONFH has attracted widespread attention in recent years. This study mainly explored whether MIR31HG polymorphism affects the risk of ONFH.</p>
</sec>
<sec>
<title>Methods</title>
<p>There were 733 males (308 alcohol-induced ONFH patients and 425 healthy controls). Seven single nucleotide polymorphisms from MIR31HG were genotyped using the Agena MassARRAY platform. Odds ratio (OR) and 95% confidence intervals (CI) <italic>via</italic> logistic regression was applied to assess the contribution of MIR31HG variants to alcoholic ONFH susceptibility.</p>
</sec>
<sec>
<title>Results</title>
<p>We found that rs10965059 was related to a lower risk of alcoholic ONFH in the overall, age, and necrotic sites analysis. Rs10965064 also showed a risk-reducing effect in the occurrence of alcoholic ONFH patients older than 40 years old.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>We confirmed that MIR31HG variants have a significant correlation with the occurrence of alcoholic ONFH among the Chinese Han male population. our findings may provide new ideas for understanding the effect of MIR31HG on the prevention and diagnosis of alcoholic ONFH.</p>
</sec>
</abstract>
<kwd-group>
<kwd>osteonecrosis of the femoral head</kwd>
<kwd>MIR31HG</kwd>
<kwd>polymorphism</kwd>
<kwd>case-control study</kwd>
<kwd>gene</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="27"/>
<page-count count="9"/>
<word-count count="3636"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Osteonecrosis of the femoral head (ONFH) is a common hip illness characterized by impaired microvascular circulation leading to the death of bone cells. It eventually causes structural changes, collapse of the femoral head, and joint dysfunction. It is reported that the age of patients with ONFH is mostly 30~50 years old, and the incidence rate is gradually increasing with the increase of age (<xref ref-type="bibr" rid="B1">1</xref>). There are 8.12 million ONFH patients in China, with approximately 150,000 to 200,000 newly diagnosed ONFH patients yearly (<xref ref-type="bibr" rid="B2">2</xref>). Some research showed that one of the common causes of ONFH was excessive drinking (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Besides, Cui et&#xa0;al. reported that alcoholic ONFH accounted for 30.7% of all femoral head necrosis in China (<xref ref-type="bibr" rid="B5">5</xref>). Nevertheless, it has been found in clinical practice that only some people who drink excessively suffer from femoral head necrosis, which suggested that genetic susceptibility may contribute to the occurrence of alcoholic ONFH. Meanwhile, a large number of reports confirmed that genetic variants were related to alcoholic ONFH predisposition (<xref ref-type="bibr" rid="B6">6</xref>&#x2013;<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Long non-coding RNAs (lncRNAs) refers to non-coding RNA with a length of over 200 nucleotides, which can regulate the physiological and pathological activities of organisms by participating in gene transcription and post-transcriptional regulation, epigenetic modification, and translation (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). Recently, lncRNAs have aroused researcher&#x2019;s concern in bone development, differentiation, and osteonecrosis. For example, Tang et&#xa0;al. found that lncRNA-OG could promote the differentiation of osteoblasts (<xref ref-type="bibr" rid="B11">11</xref>). Liu et&#xa0;al. indicated that lncRNA AK077216 facilitated bone resorption and osteoclastogenesis (<xref ref-type="bibr" rid="B12">12</xref>). Besides, a study performed by Xiang et al, which reported that lncRNA RP11-154D6 was reduced in ONFH patients and involved in the progression of ONFH (<xref ref-type="bibr" rid="B13">13</xref>).</p>
<p>MIR31HG (also named as lncHIFCAR, LOC554202) is described to participant in proliferation, differentiation, invasion of cancer cells (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). In addition, researchers have discovered that MIR31HG silence promoted osteogenic differentiation and relieved the inflammation-induced inhibition of osteogenesis (<xref ref-type="bibr" rid="B16">16</xref>). However, the role of MIR31HG in alcoholic ONFH development remains elusive. However, the role of MIR31HG in alcoholic ONFH development remains elusive.</p>
<p>Here, we explored the association of MIR31HG genetic variations with alcoholic ONFH susceptibility among the Chinese Han male population. This will help to provide new understandings for MIR31HG into the pathogenesis of alcoholic ONFH.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Study subjects</title>
<p>A total of 733 Chinese Han males (308 alcoholic ONFH patients and 425 healthy controls) were enrolled. All patients were randomly selected from Hainan Affiliated Hospital of Hainan Medical University. The patients met the criteria as following: 1) exceeded 400 mL/week (<xref ref-type="bibr" rid="B17">17</xref>) alcohol intake for more than 6 months; 2) diagnosed ONFH within one year after drinking alcohol; 3) no rheumatoid arthritis, hyperlipidemia, spinal cord cavitation, decompression sickness, osteoporosis, cardiovascular disease, and virus infection; 4) no history of steroid use; 5) The diagnosis of alcoholic ONFH by X-ray, nuclear magnetic resonance imaging (MRI), and computed tomography (CT). The stage of alcoholic ONFH patients were identified by the Ficat Classification system (<xref ref-type="bibr" rid="B18">18</xref>). Healthy people were selected based on 1) drinking habits or greater than 400 mL alcohol intake per week for more than 6 months; 2) no history of the traumatic disease (ONFH, rheumatoid arthritis, hyperlipidemia, spinal cord cavitation, decompression sickness, osteoporosis, cardiovascular disease, etc&#x2026;), and no steroid use. The study protocol was approved by the Ethics Committee of the Hainan Affiliated Hospital of Hainan Medical University, in compliance with the declaration of Helsinki. And the signature consent of participants was received.</p>
</sec>
<sec id="s2_2">
<title>SNP genotyping</title>
<p>Seven SNPs in MIR31HG were chosen with a minor allele frequency (MAF) &gt;5% in 1000 Genomes Chinese Han Beijing population. Total DNA was isolated from peripheral blood cells by GoldMag blood DNA Kit (GoldMag Co. Ltd, Xi&#x2019;an, China), and the concentration were evaluated <italic>via</italic> NanoDrop 2000 (Thermo Scientific, USA). SNP genotyping was completed through the Agena MassARRAY platform and the data were analyzed using the Agena Typer 4.0 software.</p>
</sec>
<sec id="s2_3">
<title>Data analysis</title>
<p>Student t-test was applied to evaluate age difference between the two groups. Hardy-Weinberg equilibrium (HWE) in controls was calculated using <italic>&#x3c7;</italic>
<sup>2</sup> test. The linkage between MIR31HG polymorphisms and alcoholic ONFH susceptibility was examined by odds ratio (OR) and 95% confidence interval (CI) through logistic regression. Linkage disequilibrium (LD) was analyzed by Haploview software. Multifactor dimensionality reduction (MDR) was conducted to evaluate the SNP-SNP interactions in the risk of ONFH. False positive report probability (FPRP) values and statistical power were calculated (<xref ref-type="bibr" rid="B19">19</xref>). <italic>P</italic> &lt; 0.05 was identified a significant difference.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Participants and selected SNPs in MIR31HG</title>
<p>As listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>, this study included 308 alcoholic ONFH patients and 425 healthy controls, with an average age of 43.37 &#xb1; 11.34 years and 42.73 &#xb1; 12.88 years, respectively. The age distribution between the two groups was well-matched (<italic>p</italic>=0.478).</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Characteristics of ONFH patients and controls in this study.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Variables</th>
<th valign="top" align="center">Cases (n=308)</th>
<th valign="top" align="center">Controls (n=425)</th>
<th valign="top" align="center">
<italic>p</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years</td>
<td valign="top" align="center">43.37 &#xb1; 11.34</td>
<td valign="top" align="center">42.73 &#xb1; 12.88</td>
<td valign="top" align="center">0.478</td>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2264;40</td>
<td valign="top" align="center">187 (61%)</td>
<td valign="top" align="center">246 (58%)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&gt;40</td>
<td valign="top" align="center">121 (39%)</td>
<td valign="top" align="center">179 (42%)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Clinical stages</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;I-II</td>
<td valign="top" align="center">218 (71%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;III-IV</td>
<td valign="top" align="center">90 (29%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Hip lesions</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Unilateral</td>
<td valign="top" align="center">65 (21%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Bilateral</td>
<td valign="top" align="center">243 (79%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Course, months</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&gt;22</td>
<td valign="top" align="center">103 (33%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;&#x2264;22</td>
<td valign="top" align="center">205 (67%)</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<italic>p</italic> value was calculated from student&#x2019;s t test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>We chose and genotyped seven SNPs (rs1332184, rs72703442, rs2025327, rs55683539, rs2181559, rs10965059, rs10965064) in the intron region of MIR31HG, and all SNPs in line with HWE (<italic>p</italic>&gt;0.05). And we found that rs10965059 could reduce the susceptibility of alcoholic ONFH in the allele model (<italic>p</italic> &lt; 0.001, OR = 0.48, 95%CI=0.35-0.66, <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Basic information of the selected SNPs in MIR31HG.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">SNP</th>
<th valign="top" align="center">Chr : Position</th>
<th valign="top" align="center">Role</th>
<th valign="top" align="center">AlleleA/B</th>
<th valign="top" colspan="2" align="center">MAF</th>
<th valign="top" align="center">HWE<italic>p</italic>
</th>
<th valign="top" align="center">OR (95%&#xa0;CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
<th valign="top" align="center">HaploReg</th>
</tr>
<tr>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center">Case</th>
<th valign="top" align="center">Control</th>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">rs1332184</td>
<td valign="top" align="center">9:21504203</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">A/G</td>
<td valign="top" align="center">0.291</td>
<td valign="top" align="center">0.259</td>
<td valign="top" align="center">0.256</td>
<td valign="top" align="center">1.17 (0.93-1.48)</td>
<td valign="top" align="center">0.178</td>
<td valign="top" align="left">Enhancer histone marks, DNAse</td>
</tr>
<tr>
<td valign="top" align="left">rs72703442</td>
<td valign="top" align="center">9:21515795</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">A/C</td>
<td valign="top" align="center">0.172</td>
<td valign="top" align="center">0.160</td>
<td valign="top" align="center">0.858</td>
<td valign="top" align="center">1.09 (0.82-1.44)</td>
<td valign="top" align="center">0.552</td>
<td valign="top" align="left">Enhancer histone marks, Motifs changed</td>
</tr>
<tr>
<td valign="top" align="left">rs2025327</td>
<td valign="top" align="center">9:21531629</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">C/T</td>
<td valign="top" align="center">0.141</td>
<td valign="top" align="center">0.114</td>
<td valign="top" align="center">1.000</td>
<td valign="top" align="center">1.28 (0.94-1.74)</td>
<td valign="top" align="center">0.122</td>
<td valign="top" align="left">Enhancer histone marks, DNAse, Motifs changed, Selected eQTL hits</td>
</tr>
<tr>
<td valign="top" align="left">rs55683539</td>
<td valign="top" align="center">9:21542134</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">T/C</td>
<td valign="top" align="center">0.244</td>
<td valign="top" align="center">0.245</td>
<td valign="top" align="center">0.089</td>
<td valign="top" align="center">0.99 (0.78-1.26)</td>
<td valign="top" align="center">0.938</td>
<td valign="top" align="left">Enhancer histone marks, DNAse, Motifs changed, Proteins bound</td>
</tr>
<tr>
<td valign="top" align="left">rs2181559</td>
<td valign="top" align="center">9:21543938</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">A/T</td>
<td valign="top" align="center">0.378</td>
<td valign="top" align="center">0.352</td>
<td valign="top" align="center">0.340</td>
<td valign="top" align="center">1.12 (0.90-1.39)</td>
<td valign="top" align="center">0.298</td>
<td valign="top" align="left">Enhancer histone marks, DNAse, Motifs changed, Proteins bound, Selected eQTL hits</td>
</tr>
<tr>
<td valign="top" align="left">rs10965059</td>
<td valign="top" align="center">9:21544062</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">T/C</td>
<td valign="top" align="center">0.096</td>
<td valign="top" align="center">0.181</td>
<td valign="top" align="center">0.070</td>
<td valign="top" align="center">0.48 (0.35-0.66)</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="left">DNAse, Motifs changed, Proteins bound</td>
</tr>
<tr>
<td valign="top" align="left">rs10965064</td>
<td valign="top" align="center">9:21553538</td>
<td valign="top" align="center">Intron</td>
<td valign="top" align="center">G/C</td>
<td valign="top" align="center">0.356</td>
<td valign="top" align="center">0.369</td>
<td valign="top" align="center">0.678</td>
<td valign="top" align="center">0.94 (0.76-1.17)</td>
<td valign="top" align="center">0.585</td>
<td valign="top" align="left">DNAse, Motifs changed</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Human (GRCh38.p13) reference is used for SNP annotation.</p>
</fn>
<fn>
<p>SNP, Single nucleotide polymorphism; MAF, Minor allele frequency; HWE, Hardy-Weinberg equilibrium; OR, Odds ratio; 95% CI, 95% confidence interval.</p>
</fn>
<fn>
<p>
<italic>p</italic> values were calculated from &#x3c7;<sup>2</sup> test. Bold values indicate statistical significance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Alcoholic ONFH risk assessment</title>
<p>The association of seven SNPs in MIR31HG and alcoholic ONFH risk was evaluated (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>). The results revealed that MIR31HG- rs10965059 was related to a lower risk of alcoholic ONFH under codominant (<italic>p</italic>&lt;0.001, OR=0.43, 95%CI=0.30-0.62), dominant (<italic>p</italic>&lt;0.001, OR=0.42, 95%CI=0.30-0.61) and additive models (<italic>p</italic>&lt;0.001, OR=0.45, 95%CI=0.32-0.62).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Association of MIR31HG polymorphisms with alcohol-induced ONFH.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">SNP ID</th>
<th valign="top" align="center">Model</th>
<th valign="top" align="center">Genotype</th>
<th valign="top" align="center">Case</th>
<th valign="top" align="center">Control</th>
<th valign="top" colspan="2" align="center">Crude analysis</th>
<th valign="top" colspan="2" align="center">Adjusted analysis</th>
</tr>
<tr>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center"/>
<th valign="top" align="center">OR (95% CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
<th valign="top" align="center">OR (95% CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="8" align="center">rs1332184</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">GG</td>
<td valign="top" align="center">159</td>
<td valign="top" align="center">238</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">33</td>
<td valign="top" align="center">1.36 (0.80-2.32)</td>
<td valign="top" align="center">0.258</td>
<td valign="top" align="center">1.38 (0.81-2.35)</td>
<td valign="top" align="center">0.240</td>
</tr>
<tr>
<td valign="top" align="center">AG</td>
<td valign="top" align="center">119</td>
<td valign="top" align="center">154</td>
<td valign="top" align="center">1.16 (0.85-1.58)</td>
<td valign="top" align="center">0.361</td>
<td valign="top" align="center">1.15 (0.84-1.57)</td>
<td valign="top" align="center">0.377</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">GG</td>
<td valign="top" align="center">159</td>
<td valign="top" align="center">238</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA+AG</td>
<td valign="top" align="center">149</td>
<td valign="top" align="center">187</td>
<td valign="top" align="center">1.19 (0.89-1.60)</td>
<td valign="top" align="center">0.241</td>
<td valign="top" align="center">1.19 (0.89-1.60)</td>
<td valign="top" align="center">0.244</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">AG+GG</td>
<td valign="top" align="center">278</td>
<td valign="top" align="center">392</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">30</td>
<td valign="top" align="center">33</td>
<td valign="top" align="center">1.28 (0.76-2.15)</td>
<td valign="top" align="center">0.347</td>
<td valign="top" align="center">1.30 (0.77-2.19)</td>
<td valign="top" align="center">0.319</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">1.16 (0.93-1.46)</td>
<td valign="top" align="center">0.191</td>
<td valign="top" align="center">1.17 (0.93-1.46)</td>
<td valign="top" align="center">0.185</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs72703442</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">209</td>
<td valign="top" align="center">298</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">1.00 (0.37-2.67)</td>
<td valign="top" align="center">0.997</td>
<td valign="top" align="center">1.01 (0.38-2.70)</td>
<td valign="top" align="center">0.985</td>
</tr>
<tr>
<td valign="top" align="center">AC</td>
<td valign="top" align="center">92</td>
<td valign="top" align="center">116</td>
<td valign="top" align="center">1.13 (0.82-1.57)</td>
<td valign="top" align="center">0.460</td>
<td valign="top" align="center">1.13 (0.81-1.56)</td>
<td valign="top" align="center">0.467</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">209</td>
<td valign="top" align="center">298</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA+AC</td>
<td valign="top" align="center">99</td>
<td valign="top" align="center">126</td>
<td valign="top" align="center">1.12 (0.82-1.54)</td>
<td valign="top" align="center">0.483</td>
<td valign="top" align="center">1.12 (0.82-1.54)</td>
<td valign="top" align="center">0.487</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">AC+CC</td>
<td valign="top" align="center">301</td>
<td valign="top" align="center">414</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">7</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">0.96 (0.36-2.56)</td>
<td valign="top" align="center">0.939</td>
<td valign="top" align="center">0.97 (0.37-2.59)</td>
<td valign="top" align="center">0.959</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">1.09 (0.82-1.45)</td>
<td valign="top" align="center">0.546</td>
<td valign="top" align="center">1.09 (0.82-1.45)</td>
<td valign="top" align="center">0.545</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs2025327</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">231</td>
<td valign="top" align="center">338</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">2.88 (0.97-8.55)</td>
<td valign="top" align="center">0.056</td>
<td valign="top" align="center">2.93 (0.99-8.69)</td>
<td valign="top" align="center">0.053</td>
</tr>
<tr>
<td valign="top" align="center">CT</td>
<td valign="top" align="center">67</td>
<td valign="top" align="center">87</td>
<td valign="top" align="center">1.11 (0.77-1.59)</td>
<td valign="top" align="center">0.569</td>
<td valign="top" align="center">1.12 (0.78-1.60)</td>
<td valign="top" align="center">0.547</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">231</td>
<td valign="top" align="center">338</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">CC+CT</td>
<td valign="top" align="center">87</td>
<td valign="top" align="center">92</td>
<td valign="top" align="center">1.21 (0.85-1.71)</td>
<td valign="top" align="center">0.288</td>
<td valign="top" align="center">1.22 (0.86-1.72)</td>
<td valign="top" align="center">0.271</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">CT+TT</td>
<td valign="top" align="center">298</td>
<td valign="top" align="center">420</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">10</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">2.82 (0.95-8.33)</td>
<td valign="top" align="center">0.061</td>
<td valign="top" align="center">2.86 (0.97-8.45)</td>
<td valign="top" align="center">0.058</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">1.26 (0.93-1.71)</td>
<td valign="top" align="center">0.131</td>
<td valign="top" align="center">1.27 (0.94-1.73)</td>
<td valign="top" align="center">0.121</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs55683539</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">176</td>
<td valign="top" align="center">248</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">0.79 (0.43-1.46)</td>
<td valign="top" align="center">0.454</td>
<td valign="top" align="center">0.79 (0.43-1.46)</td>
<td valign="top" align="center">0.452</td>
</tr>
<tr>
<td valign="top" align="center">TC</td>
<td valign="top" align="center">114</td>
<td valign="top" align="center">144</td>
<td valign="top" align="center">1.12 (0.82-1.53)</td>
<td valign="top" align="center">0.493</td>
<td valign="top" align="center">1.11 (0.81-1.52)</td>
<td valign="top" align="center">0.506</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">176</td>
<td valign="top" align="center">248</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT+TC</td>
<td valign="top" align="center">132</td>
<td valign="top" align="center">176</td>
<td valign="top" align="center">1.06 (0.79-1.42)</td>
<td valign="top" align="center">0.715</td>
<td valign="top" align="center">1.05 (0.78-1.42)</td>
<td valign="top" align="center">0.730</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">TC+CC</td>
<td valign="top" align="center">290</td>
<td valign="top" align="center">392</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">18</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">0.76 (0.42-1.38)</td>
<td valign="top" align="center">0.369</td>
<td valign="top" align="center">0.76 (0.42-1.38)</td>
<td valign="top" align="center">0.368</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">0.99 (0.78-1.26)</td>
<td valign="top" align="center">0.939</td>
<td valign="top" align="center">0.99 (0.78-1.25)</td>
<td valign="top" align="center">0.927</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs2181559</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">121</td>
<td valign="top" align="center">183</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">46</td>
<td valign="top" align="center">57</td>
<td valign="top" align="center">1.22 (0.78-1.92)</td>
<td valign="top" align="center">0.387</td>
<td valign="top" align="center">1.23 (0.78-1.93)</td>
<td valign="top" align="center">0.372</td>
</tr>
<tr>
<td valign="top" align="center">AT</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">185</td>
<td valign="top" align="center">1.15 (0.84-1.58)</td>
<td valign="top" align="center">0.380</td>
<td valign="top" align="center">1.15 (0.83-1.57)</td>
<td valign="top" align="center">0.405</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">121</td>
<td valign="top" align="center">183</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA+AT</td>
<td valign="top" align="center">187</td>
<td valign="top" align="center">242</td>
<td valign="top" align="center">1.17 (0.87-1.58)</td>
<td valign="top" align="center">0.306</td>
<td valign="top" align="center">1.16 (0.86-1.57)</td>
<td valign="top" align="center">0.318</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">AT+TT</td>
<td valign="top" align="center">262</td>
<td valign="top" align="center">368</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">AA</td>
<td valign="top" align="center">46</td>
<td valign="top" align="center">57</td>
<td valign="top" align="center">1.13 (0.75-1.72)</td>
<td valign="top" align="center">0.558</td>
<td valign="top" align="center">1.15 (0.75-1.75)</td>
<td valign="top" align="center">0.525</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">1.12 (0.90-1.38)</td>
<td valign="top" align="center">0.307</td>
<td valign="top" align="center">1.12 (0.90-1.38)</td>
<td valign="top" align="center">0.304</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs10965059</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">249</td>
<td valign="top" align="center">277</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">0.28 (0.06-1.32)</td>
<td valign="top" align="center">0.108</td>
<td valign="top" align="center">0.27 (0.06-1.28)</td>
<td valign="top" align="center">0.098</td>
</tr>
<tr>
<td valign="top" align="center">TC</td>
<td valign="top" align="center">55</td>
<td valign="top" align="center">137</td>
<td valign="top" align="center">0.45 (0.31-0.64)</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">
<bold>0.43 (0.30-0.62)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">249</td>
<td valign="top" align="center">277</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT+TC</td>
<td valign="top" align="center">57</td>
<td valign="top" align="center">145</td>
<td valign="top" align="center">0.44 (0.31-0.62)</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">
<bold>0.42 (0.30-0.61)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">TC+CC</td>
<td valign="top" align="center">304</td>
<td valign="top" align="center">414</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">2</td>
<td valign="top" align="center">8</td>
<td valign="top" align="center">0.34 (0.07-1.62)</td>
<td valign="top" align="center">0.175</td>
<td valign="top" align="center">0.33 (0.07-1.59)</td>
<td valign="top" align="center">0.169</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">0.46 (0.33-0.64)</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">
<bold>0.45 (0.32-0.62)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="8" align="center">rs10965064</td>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">128</td>
<td valign="top" align="center">171</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">GG</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">0.87 (0.55-1.38)</td>
<td valign="top" align="center">0.551</td>
<td valign="top" align="center">0.87 (0.54-1.38)</td>
<td valign="top" align="center">0.545</td>
</tr>
<tr>
<td valign="top" align="center">GC</td>
<td valign="top" align="center">141</td>
<td valign="top" align="center">194</td>
<td valign="top" align="center">0.97 (0.71-1.33)</td>
<td valign="top" align="center">0.855</td>
<td valign="top" align="center">0.97 (0.71-1.33)</td>
<td valign="top" align="center">0.857</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">128</td>
<td valign="top" align="center">171</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">GG+GC</td>
<td valign="top" align="center">180</td>
<td valign="top" align="center">254</td>
<td valign="top" align="center">0.95 (0.70-1.28)</td>
<td valign="top" align="center">0.719</td>
<td valign="top" align="center">0.95 (0.70-1.28)</td>
<td valign="top" align="center">0.719</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">GC+CC</td>
<td valign="top" align="center">269</td>
<td valign="top" align="center">365</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">GG</td>
<td valign="top" align="center">39</td>
<td valign="top" align="center">60</td>
<td valign="top" align="center">0.88 (0.57-1.36)</td>
<td valign="top" align="center">0.570</td>
<td valign="top" align="center">0.88 (0.57-1.36)</td>
<td valign="top" align="center">0.562</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">------</td>
<td valign="top" align="center">0.94 (0.76-1.17)</td>
<td valign="top" align="center">0.588</td>
<td valign="top" align="center">0.94 (0.76-1.17)</td>
<td valign="top" align="center">0.584</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SNP, single nucleotide polymorphism; OR, odds ratio; 95% CI, 95% confidence interval.</p>
</fn>
<fn>
<p>
<italic>p</italic> values were calculated by logistic regression analysis.</p>
</fn>
<fn>
<p>Bold values indicate statistical significance (<italic>p</italic> &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Age stratification showed that rs10965059 decreased the susceptibility to alcoholic ONFH individuals older than 40 years in the allele (<italic>p</italic>&lt;0.001, OR=0.36), codominant (<italic>p</italic>&lt;0.001, OR=0.45), dominant (<italic>p</italic>&lt;0.001, OR=0.31), and additive models (<italic>p</italic>&lt;0.001, OR=0.33, 9 <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>). Rs10965064 only reduced the alcoholic ONFH susceptibility under the dominant model (<italic>p</italic>=0.049, OR=0.67).</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Relationships between MIR31HG SNPs and alcohol-induced ONFH susceptibility based on stratification by age.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">SNP</th>
<th valign="top" align="center">Model</th>
<th valign="top" align="center">Genotype</th>
<th valign="top" colspan="4" align="center">&gt; 40 years</th>
<th valign="top" colspan="4" align="center">&#x2264; 40 years</th>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="center">Case</td>
<td valign="top" align="center">Control</td>
<td valign="top" align="center">OR (95% CI)</td>
<td valign="top" align="center">
<italic>p</italic>
</td>
<td valign="top" align="center">Case</td>
<td valign="top" align="center">Control</td>
<td valign="top" align="center">OR (95% CI)</td>
<td valign="top" align="center">
<italic>p</italic>
</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">rs10965059</td>
<td valign="top" align="center">Allele</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">340</td>
<td valign="top" align="center">380</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">213</td>
<td valign="top" align="center">311</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">T</td>
<td valign="top" align="center">34</td>
<td valign="top" align="center">106</td>
<td valign="top" align="center">
<bold>0.36 (0.24-0.54)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">25</td>
<td valign="top" align="center">47</td>
<td valign="top" align="center">0.78 (0.46-1.30)</td>
<td valign="top" align="center">0.336</td>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">154</td>
<td valign="top" align="center">142</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">95</td>
<td valign="top" align="center">135</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.20 (0.02-1.73)</td>
<td valign="top" align="center">0.142</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.44 (0.04-4.41)</td>
<td valign="top" align="center">0.488</td>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">TC</td>
<td valign="top" align="center">32</td>
<td valign="top" align="center">96</td>
<td valign="top" align="center">
<bold>0.31 (0.20-0.50)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">23</td>
<td valign="top" align="center">41</td>
<td valign="top" align="center">0.80 (0.44-1.42)</td>
<td valign="top" align="center">0.440</td>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">154</td>
<td valign="top" align="center">142</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">95</td>
<td valign="top" align="center">135</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">TT+TC</td>
<td valign="top" align="center">33</td>
<td valign="top" align="center">101</td>
<td valign="top" align="center">
<bold>0.31 (0.20-0.49)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">24</td>
<td valign="top" align="center">44</td>
<td valign="top" align="center">0.77 (0.44-1.36)</td>
<td valign="top" align="center">0.369</td>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center">Recessive</td>
<td valign="top" align="center">TC+CC</td>
<td valign="top" align="center">186</td>
<td valign="top" align="center">238</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
<td valign="top" align="center">118</td>
<td valign="top" align="center">176</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">5</td>
<td valign="top" align="center">0.28 (0.03-2.40)</td>
<td valign="top" align="center">0.243</td>
<td valign="top" align="center">1</td>
<td valign="top" align="center">3</td>
<td valign="top" align="center">0.47 (0.05-4.62)</td>
<td valign="top" align="center">0.514</td>
</tr>
<tr>
<td valign="top" align="center"/>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">
<bold>0.33 (0.21-0.51)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">0.77 (0.45-1.30)</td>
<td valign="top" align="center">0.323</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SNP, single nucleotide polymorphism; OR, odds ratio; 95% CI, 95% confidence interval.</p>
</fn>
<fn>
<p>
<italic>p</italic> values were calculated by logistic regression analysis.</p>
</fn>
<fn>
<p>Bold values indicate statistical significance (p &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Besides, the necrotic sites stratification results (<xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref>) indicated that rs10965059 played a protective role in alcoholic bilateral ONFH in the allele (OR=0.45, <italic>p</italic>&lt;0.001), codominant (OR=0.40, <italic>p</italic>&lt;0.001), dominant (OR=0.39, <italic>p</italic>&lt;0.001), and recessive model (OR=0.42, <italic>p</italic>&lt;0.001).</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Association between MIR31HG polymorphisms and ONFH risk stratified by necrotic sites.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">SNP</th>
<th valign="top" align="center">Model</th>
<th valign="top" align="center">Genotype</th>
<th valign="top" align="center">OR (95% CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" rowspan="10" align="center">rs10965059</td>
<td valign="top" rowspan="2" align="center">Allele</td>
<td valign="top" align="center">C</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">T</td>
<td valign="top" align="center">
<bold>0.45 (0.32-0.65)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="3" align="center">Codominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">0.34 (0.07-1.60)</td>
<td valign="top" align="center">0.171</td>
</tr>
<tr>
<td valign="top" align="center">TC</td>
<td valign="top" align="center">
<bold>0.40 (0.27-0.59)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Dominant</td>
<td valign="top" align="center">CC</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT+TC</td>
<td valign="top" align="center">
<bold>0.39 (0.27-0.58)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="center">Recessive</td>
<td valign="top" align="center">TC+CC</td>
<td valign="top" align="center">1.00</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="center">TT</td>
<td valign="top" align="center">0.43 (0.09-2.03)</td>
<td valign="top" align="center">0.284</td>
</tr>
<tr>
<td valign="top" align="center">Additive</td>
<td valign="top" align="center">&#x2014;&#x2013;</td>
<td valign="top" align="center">
<bold>0.42 (0.29-0.61)</bold>
</td>
<td valign="top" align="center">
<bold>&lt;0.001</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SNP, Single nucleotide polymorphism; OR, Odd ratios; CI, Confidence interval.</p>
</fn>
<fn>
<p>
<italic>p</italic> values were calculated from logistic regression.</p>
</fn>
<fn>
<p>Bold values indicate statistical significance (p &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Haplotype analysis and MDR analysis</title>
<p>We analyzed the haplotype of MIR31HG gene. <xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref> represented that there was no linkage between haplotypes and alcoholic ONFH susceptibility (<italic>p</italic>&gt;0.05). Besides, we found a LD block formed by rs72703442, rs2025327, and rs55683539 (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>Haplotype analysis of MIR31HG SNPs with alcohol-induced ONFH.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">SNP</th>
<th valign="top" rowspan="2" align="center">Haplotype</th>
<th valign="top" rowspan="2" align="center">Frequency in cases</th>
<th valign="top" rowspan="2" align="center">Frequency in controls</th>
<th valign="top" colspan="2" align="center">With adjustment</th>
<th valign="top" colspan="2" align="center">Without adjustment</th>
</tr>
<tr>
<th valign="top" align="center">OR (95% CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
<th valign="top" align="center">OR (95% CI)</th>
<th valign="top" align="center">
<italic>p</italic>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">rs72703442|rs2025327|rs55683539</td>
<td valign="top" align="center">ATT</td>
<td valign="top" align="center">0.171</td>
<td valign="top" align="center">0.157</td>
<td valign="top" align="center">1.11(0.84-1.48)</td>
<td valign="top" align="center">0.462</td>
<td valign="top" align="center">1.11(0.84-1.48)</td>
<td valign="top" align="center">0.464</td>
</tr>
<tr>
<td valign="top" align="left">rs72703442|rs2025327|rs55683539</td>
<td valign="top" align="center">CTT</td>
<td valign="top" align="center">0.073</td>
<td valign="top" align="center">0.087</td>
<td valign="top" align="center">0.83(0.57-1.21)</td>
<td valign="top" align="center">0.330</td>
<td valign="top" align="center">0.830.57-1.22)</td>
<td valign="top" align="center">0.345</td>
</tr>
<tr>
<td valign="top" align="left">rs72703442|rs2025327|rs55683539</td>
<td valign="top" align="center">CCC</td>
<td valign="top" align="center">0.140</td>
<td valign="top" align="center">0.114</td>
<td valign="top" align="center">1.26(0.93-1.71)</td>
<td valign="top" align="center">0.142</td>
<td valign="top" align="center">1.25(0.92-1.69)</td>
<td valign="top" align="center">0.153</td>
</tr>
<tr>
<td valign="top" align="left">rs72703442|rs2025327|rs55683539</td>
<td valign="top" align="center">CTC</td>
<td valign="top" align="center">0.384</td>
<td valign="top" align="center">0.362</td>
<td valign="top" align="center">1.10(0.89-1.35)</td>
<td valign="top" align="center">0.388</td>
<td valign="top" align="center">1.10(0.89-1.35)</td>
<td valign="top" align="center">0.393</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SNP, Single nucleotide polymorphism; OR, Odd ratios; CI, Confidence interval.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Linkage disequilibrium (LD) plots containing three polymorphisms from MIR31HG. Block 1 includes rs72703442, rs2025327, and rs55683539. The numbers inside the diamonds indicate the D&#x2019; for pairwise analyses.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-976165-g001.tif"/>
</fig>
<p>The Fruchterman-Rheingold of SNP-SNP interaction was presented in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>. The results of <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplemental Table&#xa0;1</bold>
</xref> revealed that rs10965059 was the best single locus model to prediction the ONFH susceptibility (testing accuracy=0.581, CVC=10/10, <italic>p</italic> &lt; 0.0001).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The Fruchterman-Reingold of SNP-SNP interactions. Each SNP is reported in per cent the value of Information Gain (IG), while numbers in the connections indicate the entropy-based IG for the SNP pairs. Orange bar indicate the high-level synergies on the phenotype, while the brown indicate a medium-level interaction, green and blue connections with negative IG values indicate redundancy or lack of synergistic interactions between the markers.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-976165-g002.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>FPRP analysis</title>
<p>As shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplemental Table&#xa0;2</bold>
</xref>, all significant results of rs10965059 remained noteworthy, at the prior probability of 0.001 and FPRP threshold of 0.2.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>We illustrated the relationship of MIR31HG polymorphisms with alcoholic ONFH susceptibility in this study. Results of our research indicated that MIR31HG-rs10965059 decreased the susceptibility of alcoholic ONFH overall. In the age stratification, we also observed that rs10965059 and rs10965064 had protective effect on alcoholic ONFH occurrence older than 40 years old. Besides, rs10965059 could reduce the alcoholic bilateral ONFH risk. These data underline the importance of MIR31HG in alcoholic ONFH occurrence and may serve as a new biomarker for the early prevention and treatment of alcoholic ONFH.</p>
<p>MIR31HG is located at the chromosomal locus 9q21.3 in humans. It has been described to participant in cell proliferation, differentiation in many diseases (<xref ref-type="bibr" rid="B20">20</xref>&#x2013;<xref ref-type="bibr" rid="B22">22</xref>). In recent years, the functional role of MIR31HG in bone-related diseases has been studied. For example, Sun et&#xa0;al. found that MIR31HG was higher in tissues of osteosarcoma patients compared with healthy controls and it could regulate osteosarcoma cell growth and migration <italic>via</italic> miR-361 (<xref ref-type="bibr" rid="B23">23</xref>). Ma et&#xa0;al. have shown that MIR31HG was elevated in chordoma patients and MIR31HG silence repressed the migration, growth, and invasion of chordoma cells (<xref ref-type="bibr" rid="B24">24</xref>). Besides, suppression of MIR31HG could facilitate the differentiation of osteoblast in human adipose-derived stem cell (<xref ref-type="bibr" rid="B16">16</xref>). Moreover, a genome-wide association studies uncovered that MIR31HG polymorphism was related to radius bone density and content in children (<xref ref-type="bibr" rid="B25">25</xref>). These evidences led us to hypothesize that MIR31HG may have pathogenic significance in alcoholic ONFH. Here, we firstly observed the contribution of MIR31HG polymorphisms to alcoholic ONFH susceptibility. Rs10965059 exerted a protective role in alcoholic ONFH occurrence in both overall and stratified analysis.</p>
<p>Rs10965059 polymorphism is in the intron region of MIR31HG. Zhao et&#xa0;al. confirmed that the common intronic WDFY4 rs877819 affects the expression of WDFY4 gene by affecting YY1 binding (<xref ref-type="bibr" rid="B26">26</xref>). Choi et&#xa0;al. also found that intronic SNP (rs2280964) significantly correlated with reduced the expression of CXCR3 gene, which resulted in changes of immune cell responses to chemokine-cytokine signaling in ex vivo and vitro (<xref ref-type="bibr" rid="B27">27</xref>). Based on the above studies, we speculatedthat rs10965059 may affect the susceptibility of alcoholic ONFH by altering the expression of MIR31HG gene. In follow-up studies, we will explore the functional consequence of intronic SNP rs10965059 <italic>in vitro</italic> and ex vivo to support our hypothesis.</p>
<p>Inevitably, there are some limitations to this study. First, we did not conduct a functional analysis, which is essential to understand the role of MIR31HG in alcoholic ONFH. Second, the subjects were all Chinese Han population, and there may be a certain selection bias. Therefore, we needed animal or cell experiments and more ethnic groups to verify our findings.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusions</title>
<p>To sum up, we confirmed that MIR31HG variants have a significant correlation with the occurrence of alcoholic ONFH in a Chinese Han male population. This may provide new ideas for the prevention and diagnosis of alcoholic ONFH.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are deposited in the Zenodo repository, accession number DOI: <ext-link ext-link-type="doi" xlink:href="10.5281/zenodo.7349781">10.5281/zenodo.7349781</ext-link>.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving human participants were reviewed and approved by Hainan Affiliated Hospital of Hainan Medical University. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>JX designed this study protocol; WL drafted the manuscript; XW performed the DNA extraction and genotyping; JC performed the data analysis; FZ performed the sample collection and information recording. JX conceived and supervised the study. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by Hainan Provincial Natural Science Foundation of China (No. 822RC808) and Project supported by the Education Department of Hainan Province (No. Hnky2022ZD-13).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2022.976165/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2022.976165/full#supplementary-material</ext-link>
</p>
  <supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<sec id="s13">
<title>Abbreviations</title>
<p>ONFH, Osteonecrosis of the femoral head; OR, odds ratio; CI, confidence intervals; MAF, minor allele frequency; HWE, Hardy-Weinberg Equilibrium; CT, computed tomography; MRI, nuclear magnetic resonance imaging; LD, linkage disequilibrium.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zalavras</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Lieberman</surname> <given-names>JR</given-names>
</name>
</person-group>. <article-title>Osteonecrosis of the femoral head: evaluation and treatment</article-title>. <source>J Am Acad Orthopaedic Surgeons</source> (<year>2014</year>) <volume>22</volume>(<issue>7</issue>):<page-range>455&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.5435/JAAOS-22-07-455</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Du</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of gene variants of transcription factors PPAR&#x3b3;, RUNX2, osterix genes and COL2A1, IGFBP3 genes with the development of osteonecrosis of the femoral head in Chinese population</article-title>. <source>Bone</source> (<year>2017</year>) <volume>101</volume>:<page-range>104&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bone.2017.05.002</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname> <given-names>G</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>He</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>P</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of circulating microRNAs aberrantly expressed in alcohol-induced osteonecrosis of femoral head</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>18926</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-019-55188-6</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>TY</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>IS</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Koo</surname> <given-names>KH</given-names>
</name>
</person-group>. <article-title>Alcohol intake and the risk of osteonecrosis of the femoral head in Japanese populations: a dose-response meta-analysis of case-control studies</article-title>. <source>Clin Rheumatol</source> (<year>2017</year>) <volume>36</volume>(<issue>11</issue>):<page-range>2517&#x2013;24</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s10067-017-3740-4</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhuang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Multicentric epidemiologic study on six thousand three hundred and ninety five cases of femoral head osteonecrosis in China</article-title>. <source>Int Orthopaedics</source> (<year>2016</year>) <volume>40</volume>(<issue>2</issue>):<page-range>267&#x2013;76</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s00264-015-3061-7</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Correlation analysis between CARMEN variants and alcohol-induced osteonecrosis of the femoral head in the Chinese population</article-title>. <source>BMC Musculoskeletal Disord</source> (<year>2020</year>) <volume>21</volume>(<issue>1</issue>):<fpage>547</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12891-020-03553-2</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Du</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ouyang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between alcohol-induced osteonecrosis of femoral head and risk variants of MMPS in han population based on a case-control study</article-title>. <source>Oncotarget</source> (<year>2017</year>) <volume>8</volume>(<issue>38</issue>):<page-range>64490&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.18632/oncotarget.16380</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>An</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Significant association between RETN genetic polymorphisms and alcohol-induced osteonecrosis of femoral head</article-title>. <source>Mol Genet Genomic Med</source> (<year>2019</year>) <volume>7</volume>(<issue>8</issue>):<elocation-id>e822</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/mgg3.822</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ohgi</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Grinstein</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs</article-title>. <source>Cell</source> (<year>2011</year>) <volume>147</volume>(<issue>4</issue>):<page-range>773&#x2013;88</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2011.08.054</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>T</given-names>
</name>
<name>
<surname>Mueller</surname> <given-names>M</given-names>
</name>
<name>
<surname>Men</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>H19 lncRNA alters DNA methylation genome wide by regulating s-adenosylhomocysteine hydrolase</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>10221</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms10221</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>LncRNA-OG promotes the osteogenic differentiation of bone marrow-derived mesenchymal stem cells under the regulation of hnRNPK</article-title>. <source>Stem Cells (Dayton Ohio).</source> (<year>2019</year>) <volume>37</volume>(<issue>2</issue>):<page-range>270&#x2013;83</page-range>. doi: <pub-id pub-id-type="doi">10.1002/stem.2937</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Dou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption <italic>via</italic> NFATc1 by inhibition of NIP45</article-title>. <source>J Cell Physiol</source> (<year>2019</year>) <volume>234</volume>(<issue>2</issue>):<page-range>1606&#x2013;17</page-range>. doi: <pub-id pub-id-type="doi">10.1002/jcp.27031</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>The role of lncRNA RP11-154D6 in steroid-induced osteonecrosis of the femoral head through BMSC regulation</article-title>. <source>J Cell Biochem</source> (<year>2019</year>) <volume>120</volume>(<issue>10</issue>):<page-range>18435&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1002/jcb.29161</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression</article-title>. <source>Mol cancer.</source> (<year>2018</year>) <volume>17</volume>(<issue>1</issue>):<fpage>162</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12943-018-0916-8</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname> <given-names>FQ</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>YW</given-names>
</name>
<name>
<surname>De</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>XH</given-names>
</name>
</person-group>. <article-title>Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer</article-title>. <source>Tumour Biol</source> (<year>2016</year>) <volume>37</volume>(<issue>6</issue>):<page-range>7693&#x2013;701</page-range>. doi: <pub-id pub-id-type="doi">10.1007/s13277-015-4644-z</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Du</surname> <given-names>N</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Inhibition of lncRNA MIR31HG promotes osteogenic differentiation of human adipose-derived stem cells</article-title>. <source>Stem Cells (Dayton Ohio)</source> (<year>2016</year>) <volume>34</volume>(<issue>11</issue>):<page-range>2707&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1002/stem.2439</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hirohata</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sugioka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fukuda</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head</article-title>. <source>Clin orthopaedics related Res</source> (<year>1988</year>) <volume>234)</volume>:<page-range>115&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1097/00003086-198809000-00021</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ficat</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Idiopathic bone necrosis of the femoral head. early diagnosis and treatment</article-title>. <source>J Bone Joint Surg Br volume.</source> (<year>1985</year>) <volume>67</volume>(<issue>1</issue>):<fpage>3</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1302/0301-620X.67B1.3155745</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wacholder</surname> <given-names>S</given-names>
</name>
<name>
<surname>Chanock</surname> <given-names>S</given-names>
</name>
<name>
<surname>Garcia-Closas</surname> <given-names>M</given-names>
</name>
<name>
<surname>El Ghormli</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rothman</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Assessing the probability that a positive report is false: an approach for molecular epidemiology studies</article-title>. <source>J Natl Cancer Inst</source> (<year>2004</year>) <volume>96</volume>(<issue>6</issue>):<page-range>434&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1093/jnci/djh075</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>M</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Nong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Knockdown of lncRNA MIR31HG inhibits cell proliferation in human HaCaT keratinocytes</article-title>. <source>Biol Res</source> (<year>2018</year>) <volume>51</volume>(<issue>1</issue>):<fpage>30</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40659-018-0181-8</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Q</given-names>
</name>
<etal/>
</person-group>. <article-title>Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression</article-title>. <source>J Exp Clin Cancer Res: CR</source> (<year>2018</year>) <volume>37</volume>(<issue>1</issue>):<fpage>214</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13046-018-0853-9</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>A</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Mei</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Decreased expression of LncRNA MIR31HG in human bladder cancer</article-title>. <source>Cancer Biomarkers: Section Dis Markers</source> (<year>2016</year>) <volume>17</volume>(<issue>2</issue>):<page-range>231&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.3233/CBM-160635</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma</article-title>. <source>Cancer Manage Res</source> (<year>2019</year>) <volume>11</volume>:<page-range>8055&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.2147/CMAR.S214569</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression</article-title>. <source>Cell Proliferation</source> (<year>2017</year>) <volume>50</volume>(<issue>6</issue>):<fpage>e12388</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cpr.12388</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chesi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Kalkwarf</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Bradfield</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Lappe</surname> <given-names>JM</given-names>
</name>
<name>
<surname>McCormack</surname> <given-names>SE</given-names>
</name>
<etal/>
</person-group>. <article-title>A trans-ethnic genome-wide association study identifies gender-specific loci influencing pediatric aBMD and BMC at the distal radius</article-title>. <source>Hum Mol Genet</source> (<year>2015</year>) <volume>24</volume>(<issue>17</issue>):<page-range>5053&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1093/hmg/ddv210</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>An intronic variant associated with systemic lupus erythematosus changes the binding affinity of Yinyang1 to downregulate WDFY4</article-title>. <source>Genes Immunity</source> (<year>2012</year>) <volume>13</volume>(<issue>7</issue>):<page-range>536&#x2013;42</page-range>. doi: <pub-id pub-id-type="doi">10.1038/gene.2012.33</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Park</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nam</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Park</surname> <given-names>SG</given-names>
</name>
<etal/>
</person-group>. <article-title>A common intronic variant of CXCR3 is functionally associated with gene expression levels and the polymorphic immune cell responses to stimuli</article-title>. <source>J Allergy Clin Immunol</source> (<year>2008</year>) <volume>122</volume>(<issue>6</issue>):<fpage>1119</fpage>&#x2013;<lpage>26.e7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2008.09.026</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>